Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Corrigendum to "Green synthesis of oxidized starch with a novel catalyst based on Fe3O4 nanoparticles and H2O2 reagent to form thermoplastic as a stable gel coating on the cardiovascular stents" [Int. J. Biol. Macromol. 219 (2022) 290-303].
Hataminia F, Majidi RF, Shabankareh ANT, Ghanbari H. Hataminia F, et al. Among authors: shabankareh ant. Int J Biol Macromol. 2024 Jan;256(Pt 1):128349. doi: 10.1016/j.ijbiomac.2023.128349. Epub 2023 Nov 22. Int J Biol Macromol. 2024. PMID: 37995791 No abstract available.
Corrigendum to "Photothermic therapy with cuttlefish ink-based nanoparticles in combination with anti-OX40 mAb achieve remission of triple-negative breast cancer" [Int. Immunopharmacol. 115 (2023) 109622].
Momenzadeh N, Hajian S, Shabankare A, Ghavimi R, Kabiri-Samani S, Kabiri H, Hesami-Zadeh K, Shabankareh ANT, Nazaraghay R, Nabipour I, Mohammadi M. Momenzadeh N, et al. Among authors: shabankareh ant. Int Immunopharmacol. 2023 Nov;124(Pt B):111035. doi: 10.1016/j.intimp.2023.111035. Epub 2023 Oct 18. Int Immunopharmacol. 2023. PMID: 37858486 No abstract available.
Photothermic therapy with cuttlefish ink-based nanoparticles in combination with anti-OX40 mAb achieve remission of triple-negative breast cancer.
Momenzadeh N, Hajian S, Shabankare A, Ghavimi R, Kabiri-Samani S, Kabiri H, Hesami-Zadeh K, Shabankareh ANT, Nazaraghay R, Nabipour I, Mohammadi M. Momenzadeh N, et al. Among authors: shabankareh ant. Int Immunopharmacol. 2023 Feb;115:109622. doi: 10.1016/j.intimp.2022.109622. Epub 2022 Dec 26. Int Immunopharmacol. 2023. PMID: 36577156